- Help
- •Contact us
- •About us
- •Sitemap
- •Advertise with the FT
- •Terms & conditions
- •Privacy policy
- •Copyright
© The Financial Times Ltd 2013 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Jun 14, 2013, the consensus forecast amongst 26 polled investment analysts covering The Procter & Gamble Company advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on May 20, 2009. The previous consensus forecast advised investors to hold their position in The Procter & Gamble Company.
| Last year | 3 months ago | 2 months ago | 4 weeks ago | Latest |
| Buy | 9 |
| Outperform | 6 |
| Hold | 11 |
| Underperform | 0 |
| Sell | 0 |
| No opinion | 0 |
The 18 analysts offering 12 month price targets for

| High | +19.9 % | 95.00 |
| Med | +7.2 % | 85.00 |
| Low | -6.6 % | 74.00 |
In 2012,
| Div growth (TTM) | +8.63% |
On Apr 24, 2013,
The next earnings announcement is expected on Aug 01, 2013. View Full Interim Financials
| Average growth rate | +3.19% |
The next earnings announcement from
| Average growth rate | +2.94% |
Procter & Gamble Co. had 3rd quarter 2013 revenues of 20.60bn. This missed the 20.73bn consensus estimate of the 19 analysts following the company. This was 7.11% below the prior year's 3rd quarter results. View Full Interim Financials
| Average growth rate | +0.63% |
Procter & Gamble Co. had revenues for the full year 2012 of 83.68bn. This was 1.36% above the prior year's results. View Full Annual Financials
| Average growth rate | +0.12% |